Excellence in Scientific Discovery
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Inter-disciplinary teams of collaborative investigators partner to foster discovery, application and translation of scientific knowledge.
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Internal and external sources of support for both established cancer research programs and promising new ideas.
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Education and professional development designed to train the next generation of cancer researchers and physicians.
National Cancer Institute Designation
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
More about our NCI Designation
May 18, 2022
‘Remote-controlled’ CAR-T cell therapy safer
Stanford researchers modified anti-cancer CAR-T cells so they can be controlled with an oral drug. The modified cells are safer, more potent and more active against solid tumors in mice.
March 25, 2022
New therapies for rare blood cancer
Hematologist Jason Gotlib wanted more effective treatments for patients with systemic mastocytosis. His research has led to the approval of two new treatments by the Food and Drug Administration.
March 10, 2022
Key molecule’s structure found at last
The structure of a critical cellular-signaling molecule has finally been discovered by Stanford researchers. The finding may lead to new therapies.